Xpert ® HIV-1 Viral Load XC
Next Generation Molecular Testing for Monitoring Viral Load and HIV-1 Infection
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
GXHIV-VL-XC-CE-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • Measurement of blood plasma HIV-1 RNA using PCR is established as the standard of care in assessing HIV-positive patient prognosis and response to antiretroviral therapy
  • It is estimated that only 75% of people living with HIV worldwide have access to viral load testing. In Low and Middle-Income Countries (LMICs), this figure is below 50%1
  • HIV viral load tests that can be deployed beyond centralized laboratories are needed to expand access to the standard of care.1
1 Malisa et al 2023 Nature Scientifc Reports | (2023) 13:4578 | https://doi.org/10.1038/s41598-023-31103-y

The Solution

  • The Xpert HIV-1 Viral Load XC test is an on-demand quantitative PCR test incorporating dual target detection for extended strain coverage
  • Using GeneXpert® technology, the Xpert HIV-1 Viral Load XC test automates the test process in one fully integrated cartridge and enables testing in laboratory or near‑patient testing environments
  • Provides users with advantages of simple workflow, fast results, and flexibility for low-to-high volume testing

The Impact

  • Improve Patient Care: Enable better treatment options by reduced loss to follow-up and shorter turn-around times between sample collection and reporting results to patients2
  • Increase Efficiency: Fast results enable earlier interventions with counseling and therapy2,3
  • Increase access to viral load testing: Deliver lab-quality results in multiple settings3,4
2 Drain, Paul K et al. “Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.” The Lancet. HIV vol. 7,4 (2020): e229-e237. doi:10.1016/S2352-3018(19)30402-3
3 Jienchi et al .2022 Oct 1;91(2):189-196. doi: 10.1097/QAI.0000000000003037. Epub 2022 Jun 13
4 Ehret et al, 2022, J Clin Vir. Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads, https://doi.org/10.1016/j.jcv.2022.105127